Company / Revenue per Share
Vir Biotechnology, Inc. Revenue per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.50
FY2025
5-year range
$0.06 / $0.65
FY2021-FY2025
Trend
-9.1%
vs FY2024
Sector context
#117 of 154
Health Care
What the data says
Vir Biotechnology, Inc.'s revenue per share of $0.50 is lower than 76% of companies in the Health Care sector (FY2025). Revenue per Share has fluctuated over the past 9 years, ranging from $0.06 in FY2021 to $1.39 in FY2018.
Based on SEC 10-K filings.
0.50 in FY2025 with a 5-year CAGR of -6.7%.
Declined from $0.65 to $0.50 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -4.9%
- 5-Year CAGR
- -6.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 154This company $0.50 Sector average $15.09
▼
-96.7% below sector average
Key checks
Key Insights
- In FY2025, revenue per share decreased 9.1% year-over-year.
- Ranks #117 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2018.
- Lowest revenue per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.50 | -9.1% |
| FY2024 | $0.55 | -14.9% |
| FY2023 | $0.65 | +11.1% |
| FY2022 | $0.58 | +816.9% |
| FY2021 | $0.06 | -91.0% |
| FY2020 | $0.71 | -22.3% |
| FY2019 | $0.91 | -34.4% |
| FY2018 | $1.39 | +10.6% |
| FY2017 | $1.26 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026